A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants
Clinical trial NCT07154095 · COMPLETED
Trial details
- NCT number
- NCT07154095
- Sponsor
- West China Second University Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2023-11-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.